Acutaas Chemicals Ltd

Acutaas Chemicals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Acutaas Chemicals Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a slight dip in the daily price, the stock’s monthly and weekly technicals reveal a complex interplay of bullish and bearish signals, reflecting a cautious but optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.

Acutaas Chemicals Ltd has demonstrated a marked shift in price momentum, supported by a series of bullish technical signals and an upgrade in its MarketsMOJO rating from Hold to Buy. The stock’s recent performance, coupled with positive monthly indicators, suggests a strengthening trend that investors should closely monitor.

Acutaas Chemicals Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a recent dip in price, the stock’s long-term performance remains robust, supported by a strong fundamental backdrop and evolving technical indicators.

Acutaas Chemicals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into its performance and outlook.

Acutaas Chemicals Ltd has demonstrated a notable shift in price momentum, supported by a range of technical indicators signalling a bullish trend. With a current market price of ₹1,748.95, up 2.69% on the day, the stock is gaining traction in the Pharmaceuticals & Biotechnology sector, reflecting improved investor sentiment and technical strength.

Acutaas Chemicals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 Oct 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into its performance and outlook.

Acutaas Chemicals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum as recent market assessments reveal a transition from a bullish to a mildly bullish trend. This change accompanies a robust year-to-date return that significantly outpaces the broader Sensex, highlighting the stock’s evolving market dynamics and investor interest.

Acutaas Chemical has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. The pharmaceutical and biotechnology company’s recent assessment highlights notable developments across quality, valuation, financial trends, and technical indicators, providing investors with a clearer perspective on its current standing.

Acutaas Chemicals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting evolving market dynamics. Recent assessment changes highlight a transition in technical indicators, suggesting a nuanced outlook for the stock amid broader market movements.

Acutaas Chemicals, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, underscoring the evolving market dynamics for this stock.

Acutaas Chemical has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that highlight the company’s ongoing financial momentum and market positioning within the Pharmaceuticals & Biotechnology sector.

Acutaas Chemicals has reached a significant milestone by touching a new 52-week high of Rs.1901.35, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement underscores the stock’s strong performance relative to its peers and the broader market.

Acutaas Chemicals has reached a significant milestone by touching a new 52-week high of Rs 1901.35 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector amid a mixed market environment.

Acutaas Chemicals has reached a new all-time high, marking a significant milestone in its market journey. The stock's recent surge reflects robust financial metrics and sustained growth within the Pharmaceuticals & Biotechnology sector, underscoring the company’s strong positioning in a competitive industry.

Acutaas Chemicals demonstrated a strong intraday performance on 24 Nov 2025, touching a high of ₹1,826.20, marking a 7.38% rise within the trading session. This surge outpaced the Pharmaceuticals & Biotechnology sector by 8.27%, reflecting notable trading activity and momentum in the stock.

Acutaas Chemicals has achieved a new 52-week high, reflecting strong performance in the small-cap pharmaceuticals and biotechnology sector. The stock has consistently risen over the past four days and is trading above key moving averages, supported by solid financial health and significant net profit growth.